Chronic Diabetes Complications Bidirectionally Linked to Mental Health Disorders
By Lori Solomon HealthDay Reporter
WEDNESDAY, Aug. 28, 2024 -- There is a consistent, bidirectional association between chronic diabetes complications (CDCs) and mental health disorders (MHDs), according to a study published online July 15 in Diabetes Care.
Maya Watanabe, from the University of Michigan in Ann Arbor, and colleagues examined bidirectional associations between the timing of CDCs and MHDs in individuals with type 1 or type 2 diabetes. The analysis included 553,552 individuals (44,735 with type 1 diabetes, 152,187 with type 2 diabetes, and 356,630 without diabetes).
The researchers found that having a CDC increased the risk for developing an MHD (hazard ratio, 1.9 to 2.9), with a higher risk observed in older age strata. Furthermore, having an MHD increased the risk for developing a CDC (hazard ratio, 1.4 to 2.5), with a higher risk observed among those ages 0 to 19 years. In younger individuals (younger than 60 years), those with type 1 diabetes were more likely to have CDCs, while those with type 2 diabetes were more likely to have MHDs. However, the bidirectional relationship between CDCs and MHDs was not affected by diabetes type.
"Most likely, a combination of direct and indirect effects and shared risk factors drive the association we are seeing," Watanabe said in a statement. "Diabetes care providers may be able to simultaneously prevent the risk of multiple complications by providing interventions to treat these shared risk factors."
Several authors disclosed ties to the pharmaceutical and medical device industries.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Mental Health, Neurodevelopmental Diagnoses in Publicly Insured Children on the Rise
WEDNESDAY, April 30, 2025 -- The percentage of publicly insured children receiving any mental health or neurodevelopmental disorder diagnosis significantly increased between 2010...
Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists
WEDNESDAY, April 30, 2025 -- Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2...
Sodium-Glucose Cotransporter 2 Inhibitors Increase Risk for Falls in Patients With Diabetes
WEDNESDAY, April 30, 2025 -- Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an independent risk factor for falls in people with type 2 diabetes, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.